Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04760951
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2021-02-16
Brief Title:
Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects
Sponsor:
Valbiotis
Organization:
Valbiotis
Study Overview
Official Title:
Randomized Placebo-controlled Double-blinded Study of the Effect of TOTUM-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HEART
Brief Summary:
This clinical study aims to assess the efficacy of TOTUM-070 a mix of 5 plant extracts on lipid metabolism in moderate hypercholesterolemic subjects The hypothesis is that TOTUM-070 daily consumed is superior to placebo for decrease of fasting blood LDL-cholesterol concentration determined by ultracentrifugation method after 24 weeks of consumption
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2020-A02809-30 | OTHER | ID-RCB | None |